## Gene Summary
RICTOR, or RPTOR Independent Companion of MTOR Complex 2, is a crucial component of the mechanistic target of rapamycin complex 2 (mTORC2). This protein complex is involved in the regulation of cell growth and survival, playing a pivotal role in cellular processes such as metabolism, apoptosis, and cytoskeletal organization. RICTOR specifically is vital for the activation of specific kinase proteins such as AKT, SGK, and PKC which are involved in various signaling pathways. The gene is expressed ubiquitously across tissue types but shows higher expression in tissues like the brain, heart, and skeletal muscle.

## Gene Drugs, Diseases, Phenotypes, and Pathways
RICTOR is implicated in several key pathways including the PI3K-AKT signaling pathway, which is fundamental to cell proliferation and survival. Dysregulation of this pathway, often through changes in RICTOR expression or function, can contribute to the development of various cancers such as breast, colorectal, and prostate cancers. In addition to its oncogenic potential, alterations in RICTOR have been associated with metabolic disorders, potentially through its impact on insulin signaling pathways. 

## Pharmacogenetics
While RICTOR itself is not typically the direct target of therapies, its role in the mTOR signaling pathway makes it indirectly significant in the pharmacogenetics context, specifically concerning cancer treatment. Drugs that target components of the mTOR pathway, such as mTOR inhibitors (e.g., sirolimus, everolimus) may have varying effectiveness based on the expression or mutation status of RICTOR. Given the gene's influence on the pathway's activity, variations in RICTOR could impact the pharmacodynamics of these drugs, affecting both efficacy and side effects. Further research into RICTOR's specific pharmacogenetic profiles could guide personalized therapy in oncology, optimizing treatment plans based on individual genetic backgrounds.